SPY307.04+1.49 0.49%
DIA257.30+2.03 0.80%
IXIC9,571.49+19.44 0.20%

PhaseBio Pharmaceuticals Q1 EPS $(0.520) Down From $(0.300) YoY, Sales $320.000K Down From $653.000K YoY

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.520) per share. This is a 73.33 percent decrease over losses of $(0.300) per share from the same period last year. The company reported $320.000

Benzinga · 05/12/2020 20:01

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.520) per share. This is a 73.33 percent decrease over losses of $(0.300) per share from the same period last year. The company reported $320.000 thousand in sales this quarter. This is a 51.00 percent decrease over sales of $653.000 thousand the same period last year.